Syneos Health, an integrated pharma solutions firm, and research software provider Protocol First have announced the extension of their strategic partnership, focused on ways to increase speed and efficiency of clinical trials. The partners plant to work toward optimizing data integration with electronic health record (EHR) systems, and support of remote source data review.
According to the companies, the collaboration comes as a response to increased demand from pharma and biopharma customers for digital solutions that foster greater communication between sites, sponsors, contract research organizations (CROs) and other functional areas, in the hopes of accelerating collection and review of trial data. The partnership (intended to deliver advanced knowledge transfer, product access, certification and more) grants Syneos “first to market” certification, with regard to training and knowledge transfer for Protocol First’s software products.
The firms report the enhanced collaboration increases Syneos’s ability to combine Protocol First’s software solutions, which integrate EHR system data into electronic data capture (EDC), with operational insights from the Syneos Heath Dynamic Assembly network. Goals of the partnership include helping to capture and analyze trial data faster and more efficiently, helping clients accelerate their products’ time to market.
“This partnership with Protocol First further strengthens our Dynamic Assembly network and supports our strategy to bring creative solutions to research sites,” said Paul Colvin, president of clinical solutions for Syneos. “By offering cutting-edge, innovative technologies and critical insights, we are working to help our clients bring medicines to market faster.”
“Syneos Health, as a first-mover participant in our Protocol First Partnership, represents a milestone in the growth and adoption of our innovative software solutions, including Clinical Pipe and P1 Source Upload for remote monitoring,” said Hugh Levaux, founder and CEO of Protocol First. “It is a harbinger of the transformation of clinical research to a digital model that ensures end-to-end data traceability in the most complex ‘precision medicine’ trials while supporting remote and decentralized study execution.”
Building upon the firms’ existing partnership, and in response to the global COVID-19 pandemic, Syneos Health and Protocol First recently published a whitepaper intended to show readers how advanced clinical trial data technology can enable clinical research associates (CRAs) to perform various tasks remotely. The white paper, Ensuring Data Quality During a Pandemic: How Innovative Technology Supports Remote Source Document Review, can be found here: https://bit.ly/2OcwREJ.
